Activity was measured by the amount of free fatty acids released by control or postheparin plasma from an artificial lipoprotein triglyceride substrate during one hour of incubation at 37°C. as ...
Although able to hydrolyze a coconut-oil emulsion, the postheparin plasma of a patient with fat-induced (Type 5) hyperlipemia was unable to hydrolyze his own, normal human or rat chylomicrons.
Lipoprotein lipase (LPL) hydrolyzes circulating triglycerides (TGs). We previously showed that 3′-end haplotypes in the LPL gene influence atherosclerosis and insulin resistance. This study asked ...
During the first 18 months after treatment with ali-pogene tiparvovec, a gene therapy recently approved in Europe to treat lipoprotein lipase deficiency (LPLD), the first patient to receive the ...
Single gene therapy for lipoprotein lipase deficiency reduces severity and frequency of pancreatitis
Over a 6-year period, patients with the genetic disease lipoprotein lipase deficiency (LPLD) who received a single gene therapy treatment of alipogene tiparvovec had a marked reduction in the severity ...
Purpose: Our aim was to test whether polymorphisms in the lipoprotein lipase (LPL) gene were associated with the progression of atherosclerosis in grafts examined in the Post-Coronary Artery Bypass ...
New Rochelle, NY, May 1, 2018--During the first 18 months after treatment with ali-pogene tiparvovec, a gene therapy recently approved in Europe to treat lipoprotein lipase deficiency (LPLD), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results